Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

Micro-RNA profile and proteins in peritoneal fluid from women with endometriosis: their relationship with sterility.

Marí-Alexandre J, Barceló-Molina M, Belmonte-López E, García-Oms J, Estellés A, Braza-Boïls A, Gilabert-Estellés J.

Fertil Steril. 2018 Apr;109(4):675-684.e2. doi: 10.1016/j.fertnstert.2017.11.036. Epub 2018 Mar 28.

PMID:
29605406
2.

Native Human Monoclonal Antibodies with Potent Cross-Lineage Neutralization of Influenza B Viruses.

Vigil A, Estélles A, Kauvar LM, Johnson SK, Tripp RA, Wittekind M.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e02269-17. doi: 10.1128/AAC.02269-17. Print 2018 May.

3.

Thickness and an Altered miRNA Expression in the Epicardial Adipose Tissue Is Associated With Coronary Heart Disease in Sudden Death Victims.

Marí-Alexandre J, Barceló-Molina M, Sanz-Sánchez J, Molina P, Sancho J, Abellán Y, Santaolaria-Ayora ML, Giner J, Martínez-Dolz L, Estelles A, Braza-Boïls A, Zorio E.

Rev Esp Cardiol (Engl Ed). 2018 Feb 10. pii: S1885-5857(17)30601-1. doi: 10.1016/j.rec.2017.12.007. [Epub ahead of print] English, Spanish.

PMID:
29439878
4.

High affinity anti-TIM-3 and anti-KIR monoclonal antibodies cloned from healthy human individuals.

Ryser S, Estellés A, Tenorio E, Kauvar LM, Gishizky ML.

PLoS One. 2017 Jul 19;12(7):e0181464. doi: 10.1371/journal.pone.0181464. eCollection 2017.

5.

A Human Biofilm-Disrupting Monoclonal Antibody Potentiates Antibiotic Efficacy in Rodent Models of both Staphylococcus aureus and Acinetobacter baumannii Infections.

Xiong YQ, Estellés A, Li L, Abdelhady W, Gonzales R, Bayer AS, Tenorio E, Leighton A, Ryser S, Kauvar LM.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e00904-17. doi: 10.1128/AAC.00904-17. Print 2017 Oct.

6.

A High-Affinity Native Human Antibody Disrupts Biofilm from Staphylococcus aureus Bacteria and Potentiates Antibiotic Efficacy in a Mouse Implant Infection Model.

Estellés A, Woischnig AK, Liu K, Stephenson R, Lomongsod E, Nguyen D, Zhang J, Heidecker M, Yang Y, Simon RJ, Tenorio E, Ellsworth S, Leighton A, Ryser S, Gremmelmaier NK, Kauvar LM.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2292-301. doi: 10.1128/AAC.02588-15. Print 2016 Apr.

7.

Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis.

Braza-Boïls A, Salloum-Asfar S, Marí-Alexandre J, Arroyo AB, González-Conejero R, Barceló-Molina M, García-Oms J, Vicente V, Estellés A, Gilabert-Estellés J, Martínez C.

Hum Reprod. 2015 Oct;30(10):2292-302. doi: 10.1093/humrep/dev204. Epub 2015 Aug 25.

PMID:
26307093
8.

MicroRNAs and angiogenesis in endometriosis.

Marí-Alexandre J, García-Oms J, Barceló-Molina M, Gilabert-Aguilar J, Estellés A, Braza-Boíls A, Gilabert-Estellés J.

Thromb Res. 2015 Feb;135 Suppl 1:S38-40. doi: 10.1016/S0049-3848(15)50439-8. Epub 2015 Feb 9. Review.

PMID:
25903532
9.

MicroRNA expression profile in endometriosis: its relation to angiogenesis and fibrinolytic factors.

Braza-Boïls A, Marí-Alexandre J, Gilabert J, Sánchez-Izquierdo D, España F, Estellés A, Gilabert-Estellés J.

Hum Reprod. 2014 May;29(5):978-88. doi: 10.1093/humrep/deu019. Epub 2014 Mar 6.

PMID:
24608518
10.

Functional analysis of two haplotypes of the human endothelial protein C receptor gene.

Medina P, Navarro S, Bonet E, Martos L, Estellés A, Bertina RM, Vos HL, España F.

Arterioscler Thromb Vasc Biol. 2014 Mar;34(3):684-90. doi: 10.1161/ATVBAHA.113.302518. Epub 2014 Jan 16.

PMID:
24436369
11.

Peritoneal fluid reduces angiogenesis-related microRNA expression in cell cultures of endometrial and endometriotic tissues from women with endometriosis.

Braza-Boïls A, Gilabert-Estellés J, Ramón LA, Gilabert J, Marí-Alexandre J, Chirivella M, España F, Estellés A.

PLoS One. 2013 Apr 19;8(4):e62370. doi: 10.1371/journal.pone.0062370. Print 2013.

12.

Association of the thrombomodulin gene c.1418C>T polymorphism with thrombomodulin levels and with venous thrombosis risk.

Navarro S, Medina P, Bonet E, Corral J, Martínez-Sales V, Martos L, Rivera M, Roselló-Lletí E, Alberca I, Roldán V, Mira Y, Ferrando F, Estellés A, Vicente V, Bertina RM, España F.

Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1435-40. doi: 10.1161/ATVBAHA.113.301360. Epub 2013 Mar 21.

PMID:
23520161
13.

microRNAs related to angiogenesis are dysregulated in endometrioid endometrial cancer.

Ramón LA, Braza-Boïls A, Gilabert J, Chirivella M, España F, Estellés A, Gilabert-Estellés J.

Hum Reprod. 2012 Oct;27(10):3036-45. doi: 10.1093/humrep/des292. Epub 2012 Aug 17.

PMID:
22904162
14.

Role of microRNAs in gynecological pathology.

Gilabert-Estelles J, Braza-Boils A, Ramon LA, Zorio E, Medina P, Espana F, Estelles A.

Curr Med Chem. 2012;19(15):2406-13. Review.

PMID:
22455593
15.

Effects of oral anticoagulant therapy and haplotype 1 of the endothelial protein C receptor gene on activated protein C levels.

Medina P, Bonet E, Navarro S, Martos L, Estellés A, Ferrando F, Vicente V, Bertina RM, España F.

Thromb Haemost. 2012 Mar;107(3):448-57. doi: 10.1160/TH11-07-0510. Epub 2012 Jan 25.

PMID:
22273845
16.

Plasminogen activator inhibitor-1 (PAI-1) 4 G/5 G polymorphism and endometrial cancer. Influence of PAI-1 polymorphism on tissue PAI-1 antigen and mRNA expression and tumor severity.

Gilabert-Estellés J, Ramón LA, Braza-Boïls A, Gilabert J, Chirivella M, España F, Estellés A.

Thromb Res. 2012 Aug;130(2):242-7. doi: 10.1016/j.thromres.2011.10.007. Epub 2011 Nov 4.

PMID:
22055623
17.

The endothelial cell protein C receptor: its role in thrombosis.

Navarro S, Bonet E, Estellés A, Montes R, Hermida J, Martos L, España F, Medina P.

Thromb Res. 2011 Nov;128(5):410-6. doi: 10.1016/j.thromres.2011.08.001. Epub 2011 Sep 7. Review.

PMID:
21903242
18.

Haplotypes of the endothelial protein C receptor gene and Behçet's disease.

Navarro S, Bonet E, Medina P, Martos L, Ricart JM, Vayá A, Todolí J, Fontcuberta J, Estellés A, España F.

Thromb Res. 2012 Apr;129(4):459-64. doi: 10.1016/j.thromres.2011.07.032. Epub 2011 Aug 17.

PMID:
21851971
19.

microRNAs expression in endometriosis and their relation to angiogenic factors.

Ramón LA, Braza-Boïls A, Gilabert-Estellés J, Gilabert J, España F, Chirivella M, Estellés A.

Hum Reprod. 2011 May;26(5):1082-90. doi: 10.1093/humrep/der025. Epub 2011 Feb 18.

PMID:
21335415
20.

Protection from the 2009 H1N1 pandemic influenza by an antibody from combinatorial survivor-based libraries.

Kashyap AK, Steel J, Rubrum A, Estelles A, Briante R, Ilyushina NA, Xu L, Swale RE, Faynboym AM, Foreman PK, Horowitz M, Horowitz L, Webby R, Palese P, Lerner RA, Bhatt RR.

PLoS Pathog. 2010 Jul 8;6(7):e1000990. doi: 10.1371/journal.ppat.1000990.

21.

Laparoscopic approach to right diaphragmatic endometriosis with argon laser: case report.

Gilabert-Estelles J, Zorio E, Castello JM, Estelles A, Gilabert-Aguilar J.

J Minim Invasive Gynecol. 2010 Jan-Feb;17(1):124-7. doi: 10.1016/j.jmig.2009.10.011.

PMID:
20129348
22.

Surrobodies with functional tails.

Xu L, Estellés A, Briante R, Kurtzman AL, Hannum CH, Kashyap AK, Horowitz L, Horowitz M, Bhatt RR, Lerner RA.

J Mol Biol. 2010 Mar 19;397(1):352-60. doi: 10.1016/j.jmb.2010.01.036. Epub 2010 Jan 25.

PMID:
20100493
23.

Influence of peritoneal fluid on the expression of angiogenic and proteolytic factors in cultures of endometrial cells from women with endometriosis.

Cosín R, Gilabert-Estellés J, Ramón LA, Gómez-Lechón MJ, Gilabert J, Chirivella M, Braza-Boïls A, España F, Estellés A.

Hum Reprod. 2010 Feb;25(2):398-405. doi: 10.1093/humrep/dep419. Epub 2009 Nov 26.

PMID:
19945964
24.

Antithrombin Cambridge II (A384S) supports a role for antithrombin deficiency in arterial thrombosis.

Roldán V, Ordoñez A, Marín F, Zorio E, Soria JM, Miñano A, España F, González-Conejero R, Pineda J, Estellés A, Fontcuberta J, Vicente V, Corral J.

Thromb Haemost. 2009 Mar;101(3):483-6.

PMID:
19277409
25.

Insights into the role of microRNAs in cardiac diseases: from biological signalling to therapeutic targets.

Zorio E, Medina P, Rueda J, Millán JM, Arnau MA, Beneyto M, Marín F, Gimeno JR, Osca J, Salvador A, España F, Estellés A.

Cardiovasc Hematol Agents Med Chem. 2009 Jan;7(1):82-90. Review.

PMID:
19149547
26.

Heritability of plasma concentrations of activated protein C in a Spanish population.

Soria JM, Navarro S, Medina P, Souto R, Buil A, Estellés A, Fontcuberta J, España F.

Blood Coagul Fibrinolysis. 2009 Jan;20(1):17-21. doi: 10.1097/MBC.0b013e3282f9ae25.

PMID:
19129726
27.

Obesity and activated protein C resistance.

Solá E, Vayá A, Villa P, España F, Estellés A, García K, Hernández-Mijares A.

Pathophysiol Haemost Thromb. 2008;36(2):64-8. doi: 10.1159/000173723. Epub 2009 Jan 5.

PMID:
19127084
28.

Vascular endothelial growth factor polymorphisms (-460C/T, +405G/C, and 936C/T) and endometriosis: their influence on vascular endothelial growth factor expression.

Cosín R, Gilabert-Estellés J, Ramón LA, España F, Gilabert J, Romeu A, Estellés A.

Fertil Steril. 2009 Oct;92(4):1214-20. doi: 10.1016/j.fertnstert.2008.08.079. Epub 2008 Oct 18.

PMID:
18930211
29.

Activated protein C levels in obesity and weight loss influence.

Solá E, Navarro S, Medina P, Vayá A, Estellés A, Hernández-Mijares A, España F.

Thromb Res. 2009 Mar;123(5):697-700. doi: 10.1016/j.thromres.2008.07.017. Epub 2008 Oct 2.

PMID:
18834618
30.

Endothelial protein C receptor polymorphisms and risk of myocardial infarction.

Medina P, Navarro S, Corral J, Zorio E, Roldán V, Estellés A, Santamaría A, Marín F, Rueda J, Bertina RM, España F; RECAVA Thrombosis Groups.

Haematologica. 2008 Sep;93(9):1358-63. doi: 10.3324/haematol.13066.

31.

The -589C>T polymorphism in the interleukin-4 gene (IL-4) is associated with a reduced risk of myocardial infarction in young individuals.

Paffen E, Medina P, de Visser MC, van Wijngaarden A, Zorio E, Estellés A, Rosendaal FR, España F, Bertina RM, Doggen CJ.

J Thromb Haemost. 2008 Oct;6(10):1633-8. doi: 10.1111/j.1538-7836.2008.03096.x. Epub 2008 Jul 25.

32.

Fibrinolysis: the key to new pathogenetic mechanisms.

Zorio E, Gilabert-Estellés J, España F, Ramón LA, Cosín R, Estellés A.

Curr Med Chem. 2008;15(9):923-9. Review.

PMID:
18473800
33.

Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression.

Ramón LA, Gilabert-Estellés J, Cosín R, Gilabert J, España F, Castelló R, Chirivella M, Romeu A, Estellés A.

Thromb Res. 2008;122(6):854-60. doi: 10.1016/j.thromres.2008.02.010. Epub 2008 Apr 18.

PMID:
18423526
34.

Haplotypes of the EPCR gene, prothrombin levels, and the risk of venous thrombosis in carriers of the prothrombin G20210A mutation.

Navarro S, Medina P, Mira Y, Estellés A, Villa P, Ferrando F, Vayá A, Bertina RM, España F.

Haematologica. 2008 Jun;93(6):885-91. doi: 10.3324/haematol.12448. Epub 2008 Apr 9.

35.

AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.

Miñano A, Ordóñez A, España F, González-Porras JR, Lecumberri R, Fontcuberta J, Llamas P, Marín F, Estellés A, Alberca I, Vicente V, Corral J.

Haematologica. 2008 May;93(5):729-34. doi: 10.3324/haematol.12271. Epub 2008 Apr 2.

36.

Fibrinolytic inhibitor levels and polymorphisms in Behçet disease and their association with thrombosis.

Ricart JM, Ramón LA, Vayá A, España F, Santaolaria ML, Todolí J, Castelló R, Fontcuberta J, Estellés A.

Br J Haematol. 2008 May;141(5):716-9. doi: 10.1111/j.1365-2141.2008.07078.x. Epub 2008 Mar 12.

PMID:
18341631
37.

Exosome nanovesicles displaying G protein-coupled receptors for drug discovery.

Estelles A, Sperinde J, Roulon T, Aguilar B, Bonner C, LePecq JB, Delcayre A.

Int J Nanomedicine. 2007;2(4):751-60.

38.

Plasminogen activator inhibitor-1 levels in severe and morbid obesity. Effect of weight loss and influence of 4G/5G polymorphism.

Solá E, Vayá A, España F, Castelló R, Ramón LA, Hernández-Mijares A, Vicente V, Estellés A.

Thromb Res. 2008;122(3):320-7. Epub 2007 Nov 26.

PMID:
18037477
39.

Fibrinogen, plasma viscosity and blood viscosity in obesity. Relationship with insulin resistance.

Solá E, Vayá A, Simó M, Hernández-Mijares A, Morillas C, España F, Estellés A, Corella D.

Clin Hemorheol Microcirc. 2007;37(4):309-18.

PMID:
17942983
40.

Polymorphisms in the endothelial protein C receptor gene and thrombophilia.

Medina P, Navarro S, Estellés A, España F.

Thromb Haemost. 2007 Sep;98(3):564-9. Review.

PMID:
17849044
41.

Erythrocyte hyperaggregation in obesity: determining factors and weight loss influence.

Solá E, Vayá A, Corella D, Santaolaria ML, España F, Estellés A, Hernández-Mijares A.

Obesity (Silver Spring). 2007 Aug;15(8):2128-34.

42.

Expression of angiogenic factors in endometriosis: relationship to fibrinolytic and metalloproteinase systems.

Gilabert-Estellés J, Ramón LA, España F, Gilabert J, Vila V, Réganon E, Castelló R, Chirivella M, Estellés A.

Hum Reprod. 2007 Aug;22(8):2120-7. Epub 2007 Jul 3.

PMID:
17609243
43.

Expression of plasminogen activator inhibitors type 1 and type 3 and urokinase plasminogen activator protein and mRNA in breast cancer.

Castelló R, Landete JM, España F, Vázquez C, Fuster C, Almenar SM, Ramón LA, Radtke KP, Estellés A.

Thromb Res. 2007;120(5):753-62. Epub 2007 Jan 29.

PMID:
17258797
44.

The role of protein C inhibitor in human reproduction.

España F, Navarro S, Medina P, Zorio E, Estellés A.

Semin Thromb Hemost. 2007 Feb;33(1):41-5. Review.

PMID:
17253188
45.

Expression of the fibrinolytic components in endometriosis.

Gilabert-Estelles J, Ramon LA, España F, Gilabert J, Castello R, Estelles A.

Pathophysiol Haemost Thromb. 2006;35(1-2):136-40. Review.

PMID:
16855359
46.

Circulating activated protein C is reduced in young survivors of myocardial infarction and inversely correlates with the severity of coronary lesions.

Zorio E, Navarro S, Medina P, Estellés A, Osa A, Rueda J, Cubillo P, Aznar J, España F.

J Thromb Haemost. 2006 Jul;4(7):1530-6.

47.

Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events.

Ricart JM, Vayá A, Todolí J, Calvo J, Villa P, Estellés A, España F, Santaolaria M, Corella D, Aznar J.

Thromb Haemost. 2006 Apr;95(4):618-24.

PMID:
16601831
48.

Lipoprotein (a) in young individuals as a marker of the presence of ischemic heart disease and the severity of coronary lesions.

Zorio E, Falco C, Arnau MA, España F, Osa A, Ramon LA, Castello R, Almenar L, Palencia MA, Estelles A.

Haematologica. 2006 Apr;91(4):562-5.

49.
50.

Exosome Display technology: applications to the development of new diagnostics and therapeutics.

Delcayre A, Estelles A, Sperinde J, Roulon T, Paz P, Aguilar B, Villanueva J, Khine S, Le Pecq JB.

Blood Cells Mol Dis. 2005 Sep-Oct;35(2):158-68.

PMID:
16087368

Supplemental Content

Loading ...
Support Center